Literature DB >> 23760282

TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury.

Zuocheng Wang1, Konrad Famulski2, Jiwon Lee3, Subhash K Das1, Xiuhua Wang3, Philip Halloran2, Gavin Y Oudit4, Zamaneh Kassiri3.   

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors of matrix metalloproteinases (MMPs). While TIMP2 and TIMP3 inhibit MMPs, TIMP3 also inhibits activation of pro-MMP2, whereas TIMP2 promotes it. Here we assessed the differential role of TIMP2 and TIMP3 in renal injury using the unilateral ureteral obstruction model. Gene microarray assay showed that post obstruction, the lack of TIMP3 had a greater impact on gene expression of intermediate, late injury- and repair-induced transcripts, kidney selective transcripts, and solute carriers. Renal injury in TIMP3(-/-), but not in TIMP2(-/-), mice increased the expression of collagen type I/III, connective tissue growth factor, transforming growth factor-β, and the downstream Smad2/3 pathway. Interestingly, ureteral obstruction markedly increased MMP2 activation in the kidneys of TIMP3(-/-) mice, which was completely blocked in the kidneys of TIMP2(-/-) mice. These changes are consistent with enhanced renal tubulointerstitial fibrosis in TIMP3(-/-) and its reduction in TIMP2(-/-) mice. The activities of tumor necrosis factor-α-converting enzyme, caspase-3, and mitogen-activated kinases were elevated in the kidneys of TIMP3(-/-) mice but not TIMP2(-/-) mice, suggesting enhanced activation of apoptotic and pathological signaling pathways only in the obstructed kidney of TIMP3(-/-) mice. Thus, TIMP2 and TIMP3 play differential and contrasting roles in renal injury: TIMP3 protects from damage, whereas TIMP2 promotes injury through MMP2 activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760282     DOI: 10.1038/ki.2013.225

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

2.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

3.  Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.

Authors:  David R Emlet; Nuria Pastor-Soler; Allison Marciszyn; Xiaoyan Wen; Hernando Gomez; William H Humphries; Seth Morrisroe; Jacob K Volpe; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

4.  Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.

Authors:  Jay L Koyner; Andrew D Shaw; Lakhmir S Chawla; Eric A J Hoste; Azra Bihorac; Kianoush Kashani; Michael Haase; Jing Shi; John A Kellum
Journal:  J Am Soc Nephrol       Date:  2014-12-22       Impact factor: 10.121

5.  APOL1 Kidney Risk Variants and Proteomics.

Authors:  Teresa K Chen; Aditya L Surapaneni; Dan E Arking; Christie M Ballantyne; Eric Boerwinkle; Jingsha Chen; Josef Coresh; Anna Köttgen; Katalin Susztak; Adrienne Tin; Bing Yu; Morgan E Grams
Journal:  Clin J Am Soc Nephrol       Date:  2022-04-26       Impact factor: 10.614

Review 6.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

7.  Remote Ischemic Preconditioning and Protection of the Kidney--A Novel Therapeutic Option.

Authors:  Alexander Zarbock; John A Kellum
Journal:  Crit Care Med       Date:  2016-03       Impact factor: 7.598

Review 8.  Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis.

Authors:  Joseph V Bonventre
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

Review 9.  The cell cycle biomarkers: promising research, but do not oversell them.

Authors:  Norbert Lameire; Jill Vanmassenhove; Wim Van Biesen; Raymond Vanholder
Journal:  Clin Kidney J       Date:  2016-05-24

Review 10.  Cell-cycle arrest and acute kidney injury: the light and the dark sides.

Authors:  John A Kellum; Lakhmir S Chawla
Journal:  Nephrol Dial Transplant       Date:  2015-06-04       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.